324784-93-2

Basic information

• Product Name: 5-phenyl-2,3,4,7-tetrahydro-1H-azepine
• Synonyms: 5-phenyl-2,3,4,7-tetrahydro-1H-azepine
• CAS NO: 324784-93-2
• Molecular Weight: 173.258
• Mol File: 324784-93-2.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 5-phenyl-2,3,4,7-tetrahydro-1H-azepine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-phenyl-2,3,4,7-tetrahydro-1H-azepine(324784-93-2)
• EPA Substance Registry System: 5-phenyl-2,3,4,7-tetrahydro-1H-azepine(324784-93-2)

Safety Data

• Hazardous Substances Data: 324784-93-2(Hazardous Substances Data)

Upstream product

• 108-86-1 bromobenzene 
• 188975-88-4 tert-butyl 4-oxoazepane-1-carboxylate 
• 1208-76-0 1-benzyl-1,2,3,5,6,7-hexahydroazepine-4-one hydrochloride 
• 1208-75-9 1-benzylazepan-4-one 
• 100-59-4 phenylmagnesium chloride 
• 1422424-42-7 C₁₇H₂₅NO₃ 
• 1202-87-5 4-phenyl-azepan-4-ol 

Downstream Products

• 1116680-21-7 C₁₉H₂₁NO₃S 
• 1116680-15-9 C₁₉H₂₁NO₃S 
• 1422423-88-8 C₂₃H₂₃N₃O₂ 

Relevant articles and documents

An elusive thermal [2 + 2] cycloaddition driven by visible light photocatalysis: Tapping into strain to access C 2-symmetric tricyclic rings

A mild and operationally simple methodology is reported for the synthesis of cyclobutane rings imbedded within a C2-symmetric tricyclic framework. The method uses visible light and an iridium-based photocatalyst to drive the oft-stated "forbidden" thermal

Antibacterial homopiperidinyl substituted 3,4 dihydro 1H[1,8]naphthyridinones

The present invention is related to novel compounds of formula (I) that inhibit the activity of the FabI enzyme which are therefore useful in the treatment of bacterial infections. It further relates to pharmaceutical compositions comprising these compounds, and chemical processes for preparing these compounds.

SUBSTITUTED AZEPINE- AND DIAZEPINE-SULFONAMIDES USEFUL TO INHIBIT 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1

In its many embodiments, the present invention relates to a novel class of substituted azepine- and diazepine-sulfonamide compounds useful to inhibit 11BETA-hydroxysteroid dehydrogenase type-1, pharmaceutical compositions containing the compounds, and met